Newly launched once-daily Parkinson's adjunct 'could simplify treatment'

Prescribers can now consider adding opicapone (Ongentys) once daily to alleviate end-of-dose motor fluctuations in patients with Parkinson's disease who cannot be stabilised on levodopa and a dopa decarboxylase inhibitor.

by Chloe Harman
COMT inhibitors reduce motor fluctuations in Parkinson's disease by increasing the half-life of levodopa. | SCIENCE PHOTO LIBRARY
COMT inhibitors reduce motor fluctuations in Parkinson's disease by increasing the half-life of levodopa. | SCIENCE PHOTO LIBRARY

To continue enjoying this article, please sign in. You can register for free for limited further access, or subscribe now for full access to all our content.

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now

Subscribe now

Benefits include:

  • Full site access
  • Subscriber exclusive content
  • Exclusive bulletins

Choose a package